VMI
VHCP Management III Portfolio holdings
AUM
$504M
This Quarter Return
-12.93%
1 Year Return
+678.37%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$138M
AUM Growth
+$138M
(+4%)
Cap. Flow
+$26.5M
Cap. Flow
% of AUM
19.29%
Top 10 Holdings %
Top 10 Hldgs %
93.9%
Holding
18
New
5
Increased
1
Reduced
–
Closed
3
Top Buys
| 1 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
$16.4M |
| 2 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$10.8M |
| 3 |
DBVT
DBV Technologies
DBVT
|
$4.09M |
| 4 |
Protagonist Therapeutics
PTGX
|
$2.85M |
| 5 |
KA
Kineta, Inc. Common Stock
KA
|
$2.75M |
Top Sells
| 1 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$10.7M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$894K |
| 3 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$493K |
Sector Composition
| 1 | Healthcare | 96.05% |
